Clinical Trial Update: An Exploratory Study of Nasonex in Patients With Moderate to Severe Persistent Allergic Rhinitis and Intermittent Asthma [Phase 3]

View source ↗

Summary

Phase 3 exploratory trial results for mometasone furoate (Nasonex) in adults with moderate-to-severe persistent allergic rhinitis and intermittent asthma; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma

Drugs mentioned

• Nasonex (mometasone furoate)

Snippet

Sponsor: Organon and Co | Conditions: Allergic Rhinitis, Asthma | Phase 3 | Status: COMPLETED | Results posted: 2010-04-30